IBB News and Press, iShares Biotechnology ETF From 04/10/24

2024-04-10 14:56:07 ET More on Markets OKE and F: The only 5% dividend stocks within the S&P 500 that are beating the index YTD 10-year yield tops 4.5% after strong CPI report Chances of June rate cut narrow after hot CPI print CPI inflation stays hot in ...

2024-04-03 08:00:00 ET Summary Welcome to another installment of our monthly Rare Stock Picks series. Today, we're highlighting March 2024 investment picks you may have missed. As you know, some Seeking Alpha analysts are more discerning by nature. Others are finding compelling id...

2024-03-29 22:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-28 08:39:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Last year was a tough one for biotech stocks . The Securities and Exchange Commission reported 41 bankruptcies following the Fed’s interest rate hiking cycle, making it difficult to ...

2024-03-28 02:01:16 ET Summary IBB tracks the performance of the rapidly advancing biotechnological sector. The need for advanced medical innovations is urgent to challenge serious ailments. The fund could benefit investors with up to 12% upside potential. ... Read...

2024-03-26 04:46:30 ET Summary The iShares Biotechnology ETF has underperformed the broader market and remains in the range set last year. Heavily weighted top 10 stocks have flat revenues are are no longer growth stocks. Further upside seems limited, and a long sideways conso...

2024-03-22 11:15:00 ET Summary A positive January for U.S. stocks is typically a prelude to a positive year, with our analysis finding the correlation to hold 80% of the time since 1928. Stocks look well-positioned to outperform bonds and cash again this year, but high valuations ...

2024-03-19 02:50:00 ET Summary Typically, a back-up in rates has led to a sell-off in stocks. We believe the current environment is different for three reasons: the degree of the move in rates, current economic cycle, and strength of mega-cap technology. In this environment, we wo...

2024-03-13 10:10:00 ET Summary Jeff Hirsch, editor-in-chief of The Stock Trader’s Almanac, and Carter Worth, CEO and founder of Worth Charting, discuss their outlook for 2024 with MoneyShow's Mike Larson. Jeff expects a strong year for stocks, with gains of 8-15% broadly sp...

2024-03-10 12:09:40 ET Summary Private sector recorded a surplus of $319B in February 2024, leading to growth in asset markets. Federal government injected $309B into the private sector, while $67B flowed out to foreign bank accounts. Fiscal impulse is rising, pointing to a po...